Multifunctional ZnO@DOX/ICG-LMHP Nanoparticles for Synergistic Multimodal Antitumor Activity.
Zhuoyue LiJingru WangJunwei LiuJianming YuJingwen WangHui WangQingchao WeiMan LiuMeiqi XuZhenhan FengTing ZhongXuan ZhangPublished in: Journal of functional biomaterials (2024)
Multifunctional nanoparticles are of significant importance for synergistic multimodal antitumor activity. Herein, zinc oxide (ZnO) was used as pH-sensitive nanoparticles for loading the chemotherapy agent doxorubicin (DOX) and the photosensitizer agent indocyanine green (ICG), and biocompatible low-molecular-weight heparin (LMHP) was used as the gatekeepers for synergistic photothermal therapy/photodynamic therapy/chemotherapy/immunotherapy. ZnO was decomposed into cytotoxic Zn 2+ ions, leading to a tumor-specific release of ICG and DOX. ZnO simultaneously produced oxygen (O 2 ) and reactive oxygen species (ROS) for photodynamic therapy (PDT). The released ICG under laser irradiation produced ROS for PDT and raised the tumor temperature for photothermal therapy (PTT). The released DOX directly caused tumor cell death for chemotherapy. Both DOX and ICG also induced immunogenic cell death (ICD) for immunotherapy. The in vivo and in vitro results presented a superior inhibition of tumor progression, metastasis and recurrence. Therefore, this study could provide an efficient approach for designing multifunctional nanoparticles for synergistic multimodal antitumor therapy.
Keyphrases
- photodynamic therapy
- fluorescence imaging
- cell death
- cancer therapy
- drug delivery
- reactive oxygen species
- quantum dots
- room temperature
- locally advanced
- pain management
- reduced graphene oxide
- dna damage
- cell cycle arrest
- visible light
- poor prognosis
- rectal cancer
- high glucose
- drug release
- heavy metals
- cell proliferation
- drug induced
- light emitting
- chemotherapy induced
- stem cells
- growth factor
- radiation therapy
- risk assessment